From Research Optoacoustic Novelty To Imaging Established in Routine diagnostics

Project Information

FRONTIER

Grant agreement ID: 190174417

DOI 10.3030/190174417

Project closed

EC signature date 17 June 2022

Start date 1 April 2022

End date 31 March 2024

Funded under

• The European Innovation Council (EIC)

Total cost € 3 581 601,23

EU contribution € 2 451 121,00

Coordinated by

ITHERA MEDICAL GMBH
Germany

Project description

Innovative technology for molecular optical imaging in deep tissue

Multispectral optoacoustic tomography (MSOT) is an innovative technology that enables molecular optical imaging in deep tissue. The technology is non-invasive and allows assessment of the concentration and distribution of molecules in the body, providing clinically important information on oxygenation, inflammation and tissue fibrosis. Despite its demonstrated scientific and clinical value, MSOT is not commercially available for the clinical market and is currently limited to research environments. The EU-funded FRONTIER project is supporting iThera Medical from Germany in optimising and translating the MSOT system from a research environment to a routine clinical imaging application.

Objective

Multispectral optoacoustic tomography (MSOT) is an innovative biomedical imaging technology that allows for molecular imaging in deep tissue. This noninvasive technology enables assessment of the concentration and distribution of a variety of clinically important molecules in the body and uniquely delivers information of e.g. oxygenation, inflammation, and fibrotic changes. MSOT has already demonstrated significant scientific and clinical value across a range of diseases and applications, making it a promising tool to diagnose diseases and monitor treatment response. Despite these early successes, the technology is not yet commercially viable on the broad clinical market and currently remains effectively confined to a research environment. FRONTIER will provide iThera Medical the means to translate an optimized MSOT system (MSOT Frontier) from a research environment to application in routine clinical imaging, thereby providing clinicians worldwide a powerful new diagnostic tool.

Fields of science

Not validated

• medical and health sciences › health sciences › social biomedical sciences
• engineering and technology › medical engineering › medical laboratory technology

Keywords

• Optoacoustic imaging
• Biophotonics
• Biomedical imaging
• Breast cancer
• Neuromuscular disease
• Inflammatory bowel disease
• Noninvasive imaging
• Molecular imaging

Programme(s)

• HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
• HORIZON.3.1.2 - The Accelerator

Topic(s)

• HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01 - Strategic Digital and Health Technologies

Call for proposal

HORIZON-EIC-2021-ACCELERATORCHALLENGES-01

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Coordinator

ITHERA MEDICAL GMBH

• Net EU contribution: € 2 451 121,00
• Address: ZIELSTATTSTRASSE 13 ; 81379 Munchen ; Germany
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Bayern › Oberbayern › München, Kreisfreie Stadt
• Region: Bayern › Oberbayern › München, Kreisfreie Stadt
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 3 581 601,23